Dawn Sugarman, PhD, is an Assistant Professor in the Department of Psychiatry at Harvard Medical School and an assistant psychologist at McLean Hospital in the Division of Alcohol, Drugs, and Addiction. She received her PhD from Syracuse University and completed predoctoral and post-doctoral fellowships at Yale School of Medicine.
Dr. Sugarman’s research primarily focuses on the use of technology in increasing access to evidence-based treatments for substance use disorders, with an emphasis on special populations such as women and individuals with substance use and co-occurring other psychiatric disorders. Dr. Sugarman received a Norman E. Zinberg Fellowship Award in 2013, and she was the inaugural recipient of the Sarles Young Investigator Award for Research on Women and Addiction in 2015. As a member of the team that won the Partners’ Connected Health Innovation Challenge in 2017, she is working on developing a digital adaptation of an evidence-based treatment for individuals with co-occurring substance use and mood disorders. Dr. Sugarman also serves as the Communications Editor for the Harvard Review of Psychiatry.